GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wockhardt Ltd (NSE:WOCKPHARMA) » Definitions » Capex-to-Revenue

Wockhardt (NSE:WOCKPHARMA) Capex-to-Revenue : 0.00 (As of Sep. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Wockhardt Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Wockhardt's Capital Expenditure for the three months ended in Sep. 2024 was ₹0.00 Mil. Its Revenue for the three months ended in Sep. 2024 was ₹8,090.00 Mil.

Hence, Wockhardt's Capex-to-Revenue for the three months ended in Sep. 2024 was 0.00.


Wockhardt Capex-to-Revenue Historical Data

The historical data trend for Wockhardt's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wockhardt Capex-to-Revenue Chart

Wockhardt Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.06 0.07 0.08 0.08

Wockhardt Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Wockhardt's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Wockhardt's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wockhardt's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wockhardt's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Wockhardt's Capex-to-Revenue falls into.



Wockhardt Capex-to-Revenue Calculation

Wockhardt's Capex-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-2160) / 27890
=0.08

Wockhardt's Capex-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 8090
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wockhardt  (NSE:WOCKPHARMA) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Wockhardt Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Wockhardt's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Wockhardt Business Description

Traded in Other Exchanges
Address
Wockhardt Towers, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Wockhardt Ltd is a drug manufacturing company focusing on pharmaceutical and biotechnology products. The company conducts research in the fields of pharmaceuticals and biotechnology while also operating its chain of Super Specialty Hospitals. The vast majority of the company's revenue is generated in Europe. The company also operates in the USA, Japan, Russia, and Rest of the world.

Wockhardt Headlines

No Headlines